Head-to-head · WeighScore
Kina vs Pomegranate Health
The verdict
Kina takes it — 70.1/100 to 69.4/100, but only just.
Kina grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Pomegranate Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Kina | Pomegranate Health |
|---|---|---|
| WeighScore | 70.1/100 | 69.4/100 |
| Grade | C | C |
| Scorecard rank | #107 | #122 |
| Semaglutide | $179/mo (starting dose, plus a separate fee, compounded) | $119/mo (starting price, compounded) |
| Tirzepatide | $179/mo (starting dose, compounded) | $149/mo (Starter tier, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #107 · C
Strengths
- Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Where it loses points
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women navigating menopause — less tailored if that is not your situation
- A separate $50 physician consultation fee applies on top of the medication price
- The compounding pharmacy partner is not named, and the full list of served states is not published
Graded #122 · C
Strengths
- No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
- The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
- Shipping is included: 'shipped discreetly to your door at no extra cost'
- Both semaglutide and tirzepatide are offered
Where it loses points
- The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
- Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
- The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
- Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.